| HOME >> MEDICINE >> TECHNOLOGY |
High-flow microinfusion into the brain parenchyma 119
Systemic administration of peptide nucleic acids 119
Introduction of antisense compounds into the CSF Pathways 119
Intrathecal administration of antisense compounds 120
Intracerebroventricular administration of antisense oligonucleotides 120
Nanoparticle-based delivery of antisense therapy to the CNS 121
Methods of delivery of ribozymes 121
Delivery aspects of RNAi therapy of CNS disorders 122
Delivery of siRNA to the CNS 122
Future drug delivery strategies applicable to the CNS 122
5.Drug Delivery in the Treatment of CNS Disorders 125
Parkinson's disease 125
Drug delivery systems for Parkinson's disease 126
Duodenal levodopa infusion 128
Transdermal drug delivery for PD 128
Transdermal dopamine agonists for Parkinson's disease 128
Transdermal administration of other drugs for Parkinson's disease 130
Intracerebral administration of GDNF 130
Cell therapy for Parkinson's disease 130
Human dopaminergic neurons for PD 132
Graft survival-enhancing drugs 132
Xenografting porcine fetal neurons 132
Encapsulated cells for PD 133
Stem cells for PD 133
Engineered stem cells for drug delivery to the brain in PD 135
Human retinal pigment epithelium cells for PD 135
Delivery of cells for PD 136
Gene therapy for Parkinson disease 136
Rationale 136
Techniques of gene therapy for PD 137
Prospects of gene therapy for Parkinson's disease 140
Companies developing gene therapy for PD 141
RNAi therapy of Parkinson's disease 141
Alzheimer disease 142
Drug delivery for Alzheimer disease 142
Blood-brain partitioning of an AMPA receptor modulator 143
Clearing amyloid through the BBB 143
Delivery of the passive antibody directly to the brain 143
Delivery of thyro
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |